Market Cap: $16.24M
AI
Accuray Incorporated
ARAY
NASDAQ (NASDAQ Global Select)USD
Market Cap: $16.24M
Accuray Incorporated (Ticker: ARAY) forges a significant decade-long partnership with the University of Wisconsin School of Medicine and Public Health to revolutionize personalized cancer care through…
Accuray Incorporated announces the appointment of Paul Miele as Senior Vice President and Chief Commercial Officer, effective April 6, 2026. This strategic decision aims to bolster the company's comme…
Accuray Advances Precision Radiation Therapy with New Technological Developments Accuray Incorporated continues to solidify its position in the radiation oncology landscape with the introduction of in…
Accuray's Leadership Shift and Strategic Developments Amidst Financial Challenges Accuray Incorporated faces a challenging financial landscape as it reports a 7% decline in total net revenue for the f…
Accuray Navigates Leadership Change Amidst Challenging Q1 Financial Results Accuray Incorporated, a leader in innovative radiation oncology solutions, reports its financial results for the first quart…
Accuray's Strategic Leadership Transition Amidst Financial Challenges Accuray Incorporated, a key player in the radiation oncology sector, reports its financial results for the first quarter of fiscal…
Accuray Welcomes New CEO with Strategic Equity Inducement Awards Accuray Incorporated announces the approval of substantial equity inducement awards to its newly appointed Chief Executive Officer, Ste…
Strategic Leadership Transition at Accuray: A Focus on Growth and Innovation Accuray Incorporated, a leader in innovative radiation therapy solutions, recently announces the appointment of Stephen La…
Accuray's Leadership Shift Paves the Way for Enhanced Operational Performance Accuray Incorporated embarks on a significant organizational transformation, marked by the appointment of Steve La Neve as…
Accuray's Leadership Shift Paves the Way for Growth and Innovation Accuray Incorporated undergoes a significant leadership change as it announces the appointment of Steve La Neve as the new Chief Exec…
Accuray Expands Access to Robotic Cancer Treatment in Australia Accuray Incorporated, a leader in innovative radiation oncology solutions, partners with 5D Clinics and Icon Group to launch its first C…
Accuray Leads Innovation in Cancer Treatment with CyberKnife Launch in Australia Accuray Incorporated, a leader in innovative radiation therapy technologies, recently announces the successful treatmen…
Accuray Partners with 5D Clinics to Revolutionize Cancer Treatment in Australia Accuray Incorporated’s recent collaboration with 5D Clinics and Icon Group marks a significant advancement in cancer tre…
Accuray Partners with UW-Madison to Advance Adaptive Radiotherapy Accuray Incorporated and the University of Wisconsin School of Medicine and Public Health (UW SMPH) forge a significant alliance throu…
Advancing Cancer Care: Accuray Partners with UW School of Medicine to Enhance Adaptive Radiotherapy Accuray Incorporated, a leader in radiation oncology, collaborates with the University of Wisconsin…
Innovative Partnership to Enhance Adaptive Radiotherapy Accuray Incorporated has formalized a strategic partnership with the University of Wisconsin School of Medicine and Public Health (UW SMPH) thro…
Accuray Unveils the Stellar Solution to Revolutionize Adaptive Radiotherapy Accuray Incorporated announces the launch of its groundbreaking Accuray Stellar™ Solution, aiming to transform adaptive radi…
Accuray Unveils Accuray Stellar™ Solution to Transform Adaptive Radiotherapy Accuray Incorporated announces the launch of its groundbreaking Accuray Stellar™ Solution, poised to revolutionize adaptive…
Accuray Sets Stage for Adaptive Radiotherapy Discussions at ASTRO 2025 Accuray Incorporated is poised to showcase its commitment to advancing radiation therapy at the upcoming American Society of Radi…
Accuray’s Commitment to Advancing Adaptive Radiotherapy at ASTRO 2025 Accuray Incorporated, a leader in radiation therapy solutions, is poised to showcase its dedication to advancing adaptive radiothe…
Accuray Prepares for Key Earnings Report Amid Industry Evolution Accuray Incorporated, a prominent player in the radiation therapy technology sector, is gearing up to release its quarterly earnings re…
Accuray Gears Up for Quarterly Earnings Report Amidst Evolving Healthcare Landscape Accuray Incorporated, a key player in the radiation therapy technology sector, prepares to unveil its quarterly earn…
Accuray's Upcoming Quarterly Earnings Report Highlights Industry Challenges and Innovations Accuray Incorporated prepares for the release of its quarterly earnings report on August 13, 2025, a pivotal…
Accuray's Innovative Advances in Radiation Therapy Technology Accuray continues to make strides in the field of radiation therapy, positioning itself as a leader in the treatment of cancer. The compan…
It appears that the content you want summarized is missing. Please provide the specific text or information regarding Accuray or related developments, and I will create the requested article based on…